Glycosan Company
BioTime is leading the next revolution in medicine – regenerative medicine. Regenerative medicine utilizes advances in stem cell biology, biomaterials, lab-generated cells and tissues, and biologics to engineer and provide healthy cells, tissues and organs to patients with chronic degenerative diseases. This revolution in medical science changes the focus from treating the symptoms of chronic and degenerative diseases to providing actual cures.
Founded Date:
2006
Last Funding Type:
Venture - Series Unknown
Headquarters:
United States
Technology:
Stem Cell
Employee Number:
501-1000
Industry:
Regenerative Medicine
Number Of Exists:
N/A
Funding Status:
M&A
Investor Type:
N/A
Investment Stage:
N/A
Total Funding:
$950K